Joseph Lacher
Analyst · Sandler O'Neill. Please go ahead
Yes. Thanks, Paul. Great question. I'm going to take it in a couple of pieces here, just hopefully trying to keep it simple, and then we can come back over the top, if that's all right. The first one and I think the simpler one to kind of roll through, is really inside our Life component with, inside the Life & Health segment. Inside there, you've seen really a one-time kind of benefits increase of roughly $3 million inside that group, a 100% one-time from that perspective. In addition to that, you saw roughly $2 million of expense, that would be one-time items that are there. Again, purely episodic related to some investments in the business, and then you saw a couple of other items that are inside, if I were to phase it, about $2 million inside that segment, that would be, I wouldn't say sporadic in nature, but they are one-time, they are not items that you wouldn't necessarily expect to see on a quarter-over-quarter basis. But you might expect us to incur that expense on 12 or an 18 month type period. In some of the items that go into that, include expenses associated with some rate filing preparation and some other things that are inside our Life business. They are a little bit less frequent than what you might normally see on the P&C side, and so that can create a little bit expense noise. On the Health side, you saw really as we've highlighted and called out about, $4 million related to a one-time -- really review of the business. And as we've continued to see a little bit of -- good growth inside that business and as we become more seasoned, what we saw is similar to what you could see in some other things we had, some older claims are in there and a few additional ones that are going to end up settling a little bit higher than what our initial assumption was. That's not really a run rate impact per se, in terms of what we're seeing coming in, but it represents really the catch-up of multiple years of business inside there, and just us having an enhanced view in terms of what might be some of the severity associated with some of those older or long dated claims. Nothing to kind of -- overly kind of think about or try to run rate in terms of your numbers, really kind of one time in total. And then when you look at some of the other things, you see that in total, we've shown good growth inside that those -- that segment. The net result of that is a little bit of upfront expense pressure that comes in, again, the remaining component there is about $2 million, and what you see there versus say in the P&C segment, and it's really kind of a mission design program, if you will, is that some of the benefits that earn out over time. where you normally DAC again not to get too much into the accounting, because some of these additional costs aren't specifically subscribed to a particular policy of that, you have an upfront expense associated with them, versus seeing that kind of over the life of the policy. So they're there, they're are part of the business, but it's not -- again something that I look at and say, hey, as our underlying cash flow projections growth, margin sustainability inside the business segment change, I don't believe it has the way, I would think about that. If I were modeling out the Life & Health segment is, look at the run rate over the last 12 months, I think that will give you a good indication of where things would be. I don't see any real material changes from that, and I really don't see any material changes from where I'd expect the year to turn out from what our expectations are.